DEVELOPMENT OF A MOLECULAR TARGETED CYTOKINE THAT SPECIFICALLY EXPANDS VGAMMA9VDELTA2 T CELLS AND POTENTIATES ANTI-TUMOR ACTIVITY

被引：0

作者：

Becklund, Bryan ^{[1
]}

Robinson, Kaitlyn ^{[1
]}

Jones, Kyle ^{[1
]}

Sanabria, Angelica ^{[1
]}

Torretti, Elisebeth ^{[1
]}

Eckles, Andrew ^{[1
]}

Hussain, Abrahim ^{[1
]}

Ahn, Sae Jeong ^{[1
]}

Pandit, Rajay ^{[1
]}

Sulzmaier, Florian ^{[1
]}

Timmer, John ^{[1
]}

Eckelman, Brendan ^{[1
]}

机构：

[1] Inhibrx, La Jolla, CA USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2022年 / 10卷

关键词：

D O I：

10.1136/jitc-2022-SITC2022.1077

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1077

引用

页码：A1119 / A1119

页数：1

共 50 条

[1] Vgamma9Vdelta2 T Cells-Based Immunotherapy Targeting BTN3 Molecules in Acute Myeloid Leukemia
Olive, Daniel
Benyamine, Audrey
Le Roy, Aude
Castellano, Remy
Gertner-Dardenne, Julie
Vey, Norbert
BLOOD, 2014, 124 (21)
[2] Zoledronic acid induces IPP release from cancer cells which causes Vgamma9Vdelta2 T cell expansion in PBMCs
Arkko, Satu
Monkkonen, Jukka
Auriola, Seppo
Dronda, Irene Rosell
Benzaid, Ismahene
Stresing, Verena
Clezardin, Philippe
Monkkonen, Hannu
BONE, 2010, 46 : S40 - S41
[3] IFN-alpha improves Vgamma9Vdelta2 T-cells response to synthetic phosphoantigens in HCV-infected patients, suggesting combined immunotherapy strategies
Cimini, Eleonora
Bonnafous, Cecile
Lalle, Eleonora
Sicard, Helene
Castilletti, Concetta
D'Offizi, Gianpiero
Capobianchi, Maria R.
Martini, Federico
Agrati, Chiara
CYTOKINE, 2009, 48 (1-2) : 77 - 77
[4] The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status
Coscia, Marta
Vitale, Candida
Peola, Silvia
Riganti, Chiara
Angelini, Daniela
Foglietta, Myriam
Pantaleoni, Francesca
Matta, Giorgia
Chiaretti, Sabina
Guarini, Anna
Drandi, Daniela
Ladetto, Marco
Bosia, Amalia
Battistini, Luca
Foa, Robin
Boccadoro, Mario
Fournie, Jean-Jacques
Massaia, Massimo
BLOOD, 2010, 116 (21) : 1482 - 1483
[5] Zoledronic acid-induced IPP/Apppl (phosphoantigen) accumulation in human breast cancer cells correlates with Vgamma9Vdelta2 T cell-mediated cancer cell death in vitro and in vivo
Benzaid, I.
Monkkonen, H.
Stresing, V.
Bonnelye, E.
Green, J.
Monkkonen, J.
Touraine, J.
Clezardin, P.
BONE, 2010, 47 : S266 - S267
[6] Combining Apoptotic Resistance and Cytokine Signaling to Improve Persistence and Anti-Tumor Activity of CAR Vδ2 T Cells In Vivo
Leong, Leonard
Narula, Mansi
Heslop, Helen Elisabeth
Brenner, Malcolm K.
Mamonkin, Maksim
Watanabe, Norihiro
BLOOD, 2023, 142
[7] TARGETING BTN2A1 MODULATES ANTI-TUMOR ACTIVITY OF VG9VD2 T CELLS
Cano, Carla
de Gassart, Aude
Pasero, Christine
Gabriac, Melanie
Fullana, Marie
Granarolo, Emilie
Hoet Rene
Imbert, Caroline
Gorvel, Laurent
Briantais, Antoine
Le Floch, Anne-Charlotte
Olive, Daniel
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A126 - A127
[8] ANTIGEN TARGETED BUTYROPHILIN HETERODIMERBASED BISPECIFIC ENGAGERS INDUCE Vγ9δ2+ T CELL-MEDIATED ANTI-TUMOR ACTIVITY
Franklin, Derek
Lai, Anne
Brewer, Faraha
Patel, Arpita
Evans, Kinsley
Hussain, Mahmud
Gonzalez, Louis
Wilson, Keith
Fromm, George
Schreiber, Taylor
De Silva, Suresh
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1247 - A1247
[9] Human Vγ9Vδ2 T cells exert anti-tumor activity independently of PD-L1 expression in tumor cells
Tomogane, Mako
Sano, Yusuke
Shimizu, Daiki
Shimizu, Teruki
Miyashita, Masatsugu
Toda, Yuki
Hosogi, Shigekuni
Tanaka, Yoshimasa
Kimura, Shinya
Ashihara, Eishi
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 573 : 132 - 139
[10] Tumor Macrophage-Mediated Cytokine Gene Delivery Improves Trafficking and Anti-Tumor Activity of CAR T Cells against Glioblastoma
Rossari, Federico
Cusimano, Melania
Birocchi, Filippo
Ranghetti, Anna
Orofino, Giorgio
Sergi, Lucia Sergi
Soldi, Monica
Colombo, Stefano
Costa, Barbara
Angel, Peter
Coltella, Nadia
Naldini, Luigi
MOLECULAR THERAPY, 2021, 29 (04) : 331 - 331

← 1 2 3 4 5 →